RUMINATIVE ANNOUNCEMENT ON NANOPARTICLES AND MONONUCLEAR PHAGOCYTIC SYSTEM
Journal Title: International Journal of Pharmaceutical Sciences and Drug Research - Year 2015, Vol 7, Issue 2
Abstract
The aim of the present review provides the relationship between therapeutic nanoparticles and mononuclear phagocytic system. Reticuloendothelial system (RES) represents a group of cells having the ability to take up and sequester inert particles and vital dyes. This includes macrophages and macrophage precursors, specialized endothelial cell lining the sinusoids of the liver, spleen and bone marrow, and the reticular cell of the lymphatic tissue (macrophages) and of the bone morrow (fibroblast). Nanoparticles are rapidly sequestered and retained by the organs comprising of the reticuloendothelial system (RES), mainly the liver, spleen and the bone marrow. Thus, targeting of the nanoparticles to the reticuloendothelial system (RES) is much simpler than to any other organ. In the liver, the particles are mainly retained by the scavenging periportal and midzonal Kupffer cells, while the hepatocytes and liver endothelial cells may play a secondary role under special pathophysiological conditions or for special physic- chemical characteristics of particles. The clearance of conventional nanoparticles has been proposed to occur by uptake of the nanoparticles by the reticuloendothelial system (RES). The mononuclear phagocytic system uptake of nanoparticles results in their rapid removal from the blood and accumulation in tissues involved in the RES, such as the liver and spleen. Uptake by the RES usually results in irreversible sequestering of the encapsulated drug in the RES, were it can be degraded. In addition, the uptake of the nanoparticles by the RES may result in acute impairment of the mononuclear phagocytic system and toxicity. Sterically stabilized nanoparticles, such as STEALTH nanoparticles, prolong the duration of exposure of the encapsulated nanoparticles in the systemic circulation. The presence of the PEG coating on the outside of the nanoparticles does not prevent uptake by the reticuloendothelial system, but simply reduces the rate of uptake.
Authors and Affiliations
Balasubramanian . , T. Sravanthi, V. Sujitha
Keywords
Related Articles
- EP ID EP625057
- DOI -
- Views 70
- Downloads 0
AN ANALYTICAL STUDY FOR DEVELOPMENT AND VALIDATION OF METHOD FOR ESTIMATION OF TOTAL BENZALKONIUM CHLORIDE CONTENT AS A PRESERVATIVE IN AZELASTINE HYDROCHLORIDE PHARMACEUTICAL OPHTHALMIC FORMULATION BY REVERSE PHASE LIQUID CHROMATOGRAPHY APPROACH
A novel, sensitive, specific, accurate and reproducible reverse phase high performance liquid chromatographic analytical method (RP-HPLC) was developed and validated for estimation of total benzalkonium chloride (BKC) co...
IN SILICO ADME, BIOACTIVITY AND TOXICITY PREDICTION OF SOME SELECTED ANTI-EPILEPTIC AGENTS
Epilepsy is a brain disorder characterized by partial or generalized spontaneous (unprovoked) recurrent epileptic seizures and often, comorbidities such as anxiety and depression. Epilepsy is fourth most common neurologi...
EVALUATION OF CLINICAL EFFICACY AND TOLERANCE OF KHASCEEZE –SF COUGH SYRUP
Fifty patients of either sex aged 15 - 65 years entered the study to test the efficacy and tolerability of a herbal preparation known as Khasceeze-SF Cough Syrup. They were studied for cough and related symptoms such as...
THERAPEUTIC L-ASPARAGINASE ACTIVITY OF BACTERIA ISOLATED FROM MARINE SEDIMENTS
L-Asparaginase, a therapeutic enzyme used in lymphoblastic leukemia and lymphosarcoma chemotherapy which is derived mostly from the bacterial sources Escherichia coli and Erwinia sp. The long term administration of the d...
COMPATIBILITY STUDIES OF ATORVASTATIN CALCIUM WITH SELECTED EXCIPIENTS BY MEANS OF THERMAL AND FT-IR SPECTROSCOPIC METHODS FOR THE DEVELOPMENT OF IMMEDIATE RELEASE TABLET
The objectives of present investigation is to evaluate the compatibility of Atorvastatin calcium with immediate release excipients and to optimize the tablet which release is best comparable with innovator product by var...